Synthesis of pochoxime prodrugs as potent HSP90 inhibitors
摘要:
Pochoximes are potent inhibitors of heat shock protein 90 (HSP90) based on the radicicol pharmacophores. Herein we present a pharmacokinetics and pharmacodynamics evaluation of this compound series as well as a phosphate prodrug strategy to facilitate formulation and improve oral bioavailability. (C) 2009 Elsevier Ltd. All rights reserved.
Synthesis of pochoxime prodrugs as potent HSP90 inhibitors
摘要:
Pochoximes are potent inhibitors of heat shock protein 90 (HSP90) based on the radicicol pharmacophores. Herein we present a pharmacokinetics and pharmacodynamics evaluation of this compound series as well as a phosphate prodrug strategy to facilitate formulation and improve oral bioavailability. (C) 2009 Elsevier Ltd. All rights reserved.
[EN] POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES<br/>[FR] DÉRIVÉS DE POCHOXIME CONVENANT POUR LE TRAITEMENT DE PATHOLOGIES EN RAPPORT AVEC HSP90
申请人:UNIV STRASBOURG
公开号:WO2012052843A1
公开(公告)日:2012-04-26
The present invention includes novel derivatives, analogs, and intermediates of the natural products radicicol, pochonins, pochoximes, and their syntheses. The present invention also provides a pharamceutical composition comprising the present compound and the use of the compound as inhibitors of kinases and of the enzyme family known as heat shock protein 90 (HSP90).
[EN] MACROCYCLIC PRODRUG COMPOUNDS USEFUL AS THERAPEUTICS<br/>[FR] COMPOSÉS DE PROMÉDICAMENTS MACROCYCLIQUES UTILISÉS COMME AGENTS THÉRAPEUTIQUES
申请人:NEXGENIX PHARMACEUTICALS
公开号:WO2009105755A3
公开(公告)日:2009-11-12
Macrocyclic prodrug compounds useful as therapeutics
申请人:Nexgenix Pharmaceuticals
公开号:EP2254880B1
公开(公告)日:2016-08-17
Macrocyclic Prodrug Compounds Useful as Therapeutics
申请人:Heck James
公开号:US20110190237A1
公开(公告)日:2011-08-04
The present invention includes macrocyclic prodrug compounds, pharmaceutical compositions containing them. The present invention also includes use of these compounds in the treatment of various diseases including an autoimmune disease, an inflammatory disease, a neurological or neurodegenerative disease, cancer, a cardiovascular disease, allergy, asthma, a hormone-related disease, and tumors or symptoms resulting from neurofibromatosis.
POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES
申请人:Winssinger Nicolas
公开号:US20140031302A1
公开(公告)日:2014-01-30
The present invention includes novel derivatives, analogs, and intermediates of the natural products radicicol, pochonins, pochoximes, and their syntheses. The present invention also provides a pharmaceutical composition comprising the present compound and the use of the compound as inhibitors of kinases and of the enzyme family known as heat shock protein 90 (HSP90).